Molluscum Contagiosum: An Update on Efficacy and Treatment Strategies

The presentation discusses the common viral skin infection molluscum contagiosum, emphasizing its high transmission rate and the challenges in treating it effectively. Parents often express frustration when advised by pediatricians to leave the lesions untreated, leading to a larger outbreak among their children. The speaker recounts personal experiences with their own child having molluscum, highlighting the emotional distress families face when dealing with this condition. The history of molluscum is noted, with its recognition dating back over 200 years, and its prevalence in various age groups across the globe is discussed. Current treatments include newer FDA-approved medications like Berdazimir gel and the Cantharidin-based therapy, which have shown promising results in clinical trials for lesion reduction. The presentation also addresses the psychological impact of molluscum on children, affecting their social interactions and self-esteem. It cautions that some treatments may cause inflammation or irritation, and stresses the importance of educating parents on the nature of the infection, its management, and the need for multiple treatment sessions. The speaker indicates a shift towards more effective treatment options in the future and encourages continuous education for both healthcare professionals and families affected by this infection.